Definitive Contract HHSN268201700008C
Award Date 11/14/16
Potential Completion Date 5/14/20
Potential Value $795K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
South Miami, FL 33146, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
23
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the University of Miami, a private non-profit university, for $305,761.68 to SCALE UP PROCESSES FOR MSC DERIVED EXOSOMES. The award is part of the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) indefinite delivery/indefinite quantity (IDIQ) contract. No set-aside designation was used. The University of...
- This is a $154,494.31 cost-reimbursement delivery order awarded by the National Heart Lung and Blood Institute (NHLBI) to the University of Miami for production assistance for cellular therapies (PACT) - cell processing facilities. The contract is part of the larger PACT-CPF program, which provides cell manufacturing and process development services. The University of Miami, a private non-profit research university, will be performing the work in South Miami, Florida. This delivery order does...
- The University of Miami Research Administration - Coral Gables Division was awarded a $162,299 delivery order under an unspecified government-wide acquisition contract by the National Institutes of Health's National Heart, Lung and Blood Institute. The delivery order is for Task Area B1, involving protocol development and training for Visit 3 of a basic examination. Performance will take place in South Miami, Florida over an approximately seven-month period concluding in mid-January 2020. The...
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order contract valued at $99,918.43 to the University of Miami Office of Research Administration - School of Medicine Division. The contract does not have a set-aside designation, indicating it was competed on a full and open basis. The University of Miami, a private non-profit research university, is providing specialized medical and...
- This is a $1,025,823.67 delivery order award to the University of Miami Research Administration - Coral Gables Division, doing business as University of Miami Coral Gables, by the National Heart Lung and Blood Institute. The award is for the Hispanic Community Health Study - Study of Latinos (HCHS-SOL) Field Center Task Area B Year 3. The overall contract has a completion date of January 31, 2024. The contract is a cost-no-fee arrangement and does not have a set-aside designation. The University...
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $1,180,889.00 firm-fixed-price delivery order contract to the University of Miami Office of Research Administration - School of Medicine Division for "Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities". This delivery order is part of a larger PACT-CPF Indefinite Delivery Contract vehicle held by the University of Miami....
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $723,091.34 delivery order contract to the University of Miami to produce fibroblast master and working cell banks. The contract is part of the larger Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The work requires the University of Miami to establish necessary...
- The University of Miami has been awarded a delivery order valued at $13.4M under a larger Indefinite Delivery Contract (IDC) with the National Heart, Lung, and Blood Institute (NHLBI) for core study operations at the Hispanic Community Health Study - Study of Latinos (HCHS-SOL) Miami Field Center. This is a cost-type contract with no fee, running through November 2032, and will be performed in South Miami, Florida. The work involves comprehensive epidemiological research and data collection...
- This is a $150,000 grant awarded by the Shared Services Center, a civilian federal agency, to the University of Miami for the execution of a balanced science program. The grant is based on discipline-specific guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and direction from Congress. The grant is a research contract with no set-aside designation, indicating it was awarded through open competition. The University of Miami is the prime...
- This federal contract award is for "PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT) - CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR PCT0005-02: CRYOPRESERVATION TECHNICAL STUDY" through a Delivery Order under the larger "Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF)" contract vehicle. The prime contractor is the University of Miami, a private non-profit research university, and the contract is...
This federal contract award with ID HHSN268201700008C was issued by the National Heart Lung and Blood Institute, a civilian agency, to the University of Miami in the amount of $794,934.76. The contract, which does not have a set-aside designation, is for the delivery of "E-SELECTIN/AAV FOR THERAPEUTIC REVERSAL OF LIMB ISCHEMIA" services. The University of Miami, a private non-profit research university, has extensive experience as both a prime contractor and subcontractor on federal research contracts and grants, often collaborating with other academic institutions. The contract has a completion date of May 14, 2020 and is a definitive contract with a cost no fee pricing type.
Generated 9/7/24, 10:47 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NHLBI Vascular Innovations/Interventions and Therapeutic Advances (VITA) | NHLBI-CSB-HV-2017-01-JS | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 6/18/15, 7:38 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Funding Only Action | 0$ | 6/7/24 | |
| P00006 | Close Out | ($22k) | 3/7/24 | |
| P00005 | Other Administrative Action | ($22k) | 8/22/23 | |
| P00004 | Other Administrative Action | ($42k) | 8/22/22 | |
| P00003 | Change Order | $0 | 11/14/19 |